Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function

European Journal of Clinical Pharmacology

Volumn 49, Issue 3, 1995, Pages 229-235

  Barbhaiya, R H ^a   Brady, M E ^a   Shukla, U A ^a   Greene, D S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

antidepressive agents; Nefazodone; pharmacokinetics; Renal impairment

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; DRUG METABOLITE; HYDROXYNEFAZODONE; NEFAZODONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; STEADY STATE;

ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PIPERAZINES; SEROTONIN AGONISTS; TRIAZOLES;

EID: 0028802797     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF00192384     Document Type: Article

References (25)

1. A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression
2. Triazolo antidepressants do not inhibit monoamine oxidase
3. Nefazodone: preclinical pharmacology of a new antidepressant
4. Receptor binding and atypical antidepressant drug discovery
5. Placebo controlled dose-ranging trials designs in phase II development of nefazodone
6. Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment
7. Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses
8. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma
9. Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites
10. Polymorphic dextromethorphan metabolism: Cosegregation of oxidative o-demethylation with debrisoquin hydroxylation
11. Comparative evaluation of the effects of isradipine and diltiazem on antipyrine and indocyanine green clearance in elderly volunteers
12. High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics
13. An application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time
14. Analysis of transformations
15. Disposition kinetics of buspirone in patients with renal of hepatic impairment after administration of single and multiple doses
16. Fluoxetine kinetics and protein binding in normal and impaired renal function
17. Clinical implications of the pharmacology of sertraline
18. Pharmacokinetics of nefazodone in extensive and poor metabolizers of dextromethorphan